A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/17 (2006.01) A61P 13/12 (2006.01) G01N 33/68 (2006.01)
Patent
CA 2749985
There is no shared technical feature among all of Groups 1-111. The shared technical feature of Groups I and III is a method for characterizing renal failure comprising, inter alia, comparing levels of gelsolin. However, this is not an improvement over the prior art of US 5260224A to Stossel et al. (9 Novemeber 1993; hereinafter "Stossel") that teaches the use of gelosin in the diagnosis and treatment of renal disease (abstract, col 6 In 7-13, col 6 In 43- 54, col 3 In 8-13). The shared technical feature of Groups 11 and III is a method for characterizing renal failure comprising, inter alia, comparing levels of actin from the subject. However, this is not an improvment over the prior art of Stossel that teaches the use of actin in the diagnosis and treatment of renal disease (abstract, col 1 In 11-17, col 3 In 36-67; claimi).
L'invention porte, en partie, sur l'utilisation de la gelsoline pour diagnostiquer, surveiller et traiter des sujets avec une insuffisance rénale (par exemple, des sujets atteints d'une insuffisance rénale chronique en dialyse).
Karumanchi Ananth
Lee Po-Shun
Stossel Thomas P.
Thadhani Ravi
Beth Israel Deaconess Medical Center Inc.
Smart & Biggar
The Brigham And Women's Hospital Inc
The General Hospital Corporation
LandOfFree
Diagnostic and therapeutic uses of gelsolin in renal failure does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnostic and therapeutic uses of gelsolin in renal failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic and therapeutic uses of gelsolin in renal failure will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1496715